b'Other Efficacy01. Bacteriain vitro E. coli:6 Log 10reduction in 5 minutes DataMRSA: 5 Log 10reduction in 10 minutes Agile Sciences, Inc. (2014). Unpublished report.Third party researchers have conducted02. C. difficile sporesin vitromultiple studies to gauge the efficacy of the CleanSurface technology.Up to 1.46 Log 10reduction in 45 minutes Cadnum J, Livingston S. (2018). Unpublished data, Curtis Donskey Research Services. 03. Virusesin vitro Up to 3 Log 10reduction of murine norovirus CW1 Day C, Utah State University. (2016). Unpublished report.Urna justo bibendum justo, vitae Key Pathogens Eliminated and ReducedReduction AIONX Solution: luctus massa purus non dui. Morbi Clostridium difficile 100% Continuous Cleaningtellus lacus, tincidunt non nisl ut.Impact on Patient CareEnterococcus 79%Bacteroides fragilis 100%Chart shows percent reduction inStaphylococcus aureus 45%abundance of key pathogens across allWhat does the ability of samples. (p 0.05)Acinetobacter baumannii 100% CleanSurfaces to reduce Pathogenic Streptococcus 45% environmental contamination Morganella morganii 100% throughout a targeted unit mean to patient care? Mycobacterium abscessus 100%AIONX Surface CoversLamendella R, Wright, JR, et al. unpublished data (Feb 2019) AionX 39'